Kura Oncology Inc

NASDAQ:KURA   3:59:59 PM EDT
13.50
+0.95 (+7.57%)
Earnings Announcements

Kura Oncology Reports First Quarter 2022 Financial Results

Published: 05/04/2022 21:54 GMT
Kura Oncology Inc (KURA) - Kura Oncology Reports First Quarter 2022 Financial Results.
Cash Runway Through 2024.
Qtrly Net Loss per Share, Basic and Diluted $0.49.
Q1 Earnings per Share View $-0.52 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.50

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.53

More details on our Analysts Page.